-
Sanofi Restructures R&D Group
contractpharma
June 24, 2019
To eliminate 466 jobs in France and Germany as part of a reorganization to focus on its immuno-oncology pipeline and gene therapies.
-
AHA News: This Faulty Gene May Help Predict Heart Muscle Disease
drugs
June 21, 2019
This Faulty Gene May Help Predict Heart Muscle Disease.
-
Axovant, Yposkesi Ink Gene Therapy Pact
contractpharma
June 21, 2019
CDMO to support the global development and commercialization of Axovant’s gene therapy programs.
-
Voyager Therapeutics, Sanofi Genzyme Restructure Gene Therapy Alliance
contractpharma
June 18, 2019
Voyager gains worldwide rights to VY-HTT01 Huntington’s disease program and ex-U.S. rights to VY-FXN01 Friedreich’s ataxia program for $10 million upfront.
-
Catalent Biologics, IVERIC bio Ink Mfg. Pact
contractpharma
June 18, 2019
Paragon Gene Therapy, part of Catalent Biologics, will provide materials for preclinical and Phase 1/2 trials for IVERIC’s gene therapy product candidates.
-
Gene Test Might Someday Gauge Your Heart Attack Risk
drugs
June 12, 2019
Gene Test Might Someday Gauge Your Heart Attack Risk.
-
Biogen Completes $800M Nightstar Acquisition
contractpharma
June 10, 2019
Gains two mid- to late-stage clinical assets and preclinical programs in ophthalmology.
-
Cleveland researchers test novel gene therapy for glioblastoma
worldpharmanews
June 10, 2019
Cleveland researchers test novel gene therapy for glioblastoma.
-
Aldevron to Build 14-Acre Gene Therapy Mfg. Campus
contractpharma
June 04, 2019
Annual capacity will exceed $1 billion of plasmid DNA, RNA, gene editing enzymes, and other biologics.
-
Blood Test Could Spot Multiple Cancer Types, Researchers Say
drugs
May 30, 2019
A gene-based blood test can accurately detect breast, colorectal, lung, ovarian, pancreatic, gastric or bile duct cancers in patients, researchers report.